Testing for Colorectal Cancer Has Been Anything but Routine Until Now.
|
|
- Julian George
- 6 years ago
- Views:
Transcription
1 TM Testing for Colorectal Cancer Has Been Anything but Routine Until Now. Compliance rates for recommended colorectal cancer testing are dismal. The SimpliPro Colon test is a laboratory service designed to reverse that trend with a noninvasive blood test service that measures specific protein markers and fits seamlessly into routine patient workups for those with an elevated risk* for colorectal cancer.
2 The Best Test is the One That Gets Done %2 Compliance reported with blood test Better Colorectal Cancer Testing Compliance Results in Early Detection 62%3 Colonoscopy compliance 28%4 Fecal test compliance 90%5 5-year survival rate, if detected early 13%5 5-year survival rate, if detected in late stages *Elevated-risk patients are defined as those who presented with the symptoms observed in the SimpliPro Colon test studies.
3 Introducing the SimpliPro Colon Test The SimpliPro Colon test is a laboratory service available only to healthcare providers to enable better compliance for diagnostic colonoscopy for patients presenting with symptoms associated with colorectal cancer. It is a blood-based test that measures and analyzes 11 protein markers associated with a risk of colorectal cancer. As a group, these proteins have been found to correlate with a higher or lower risk of positive diagnosis of colorectal cancer and/or advanced adenoma using Its unique combination of convenience and performance makes the SimpliPro Colon test ideal for helping to drive greater compliance for colonoscopy. Making Compliance the New Routine The SimpliPro Colon test requires only a blood draw and can be performed in your office or lab. There are no new procedures for you and your staff to learn. There is no handling of feces or waiting for at-home tests to be returned. Seamless Integration The SimpliPro Colon test is administered like other blood tests, fitting ideally into your practice s routine. Increased Compliance The SimpliPro Colon test may help increase compliance for colonoscopy among your elevated-risk patients.
4 Ideal For Elevated-Risk Patients * There are many risk factors associated with colorectal cancer and its symptoms can take various forms. The symptoms associated with subjects in the development studies included: Unexplained weight loss Anemia Change in bowel habits or consistency of stool, including diarrhea or constipation Abdominal discomfort such as cramps, gas, or pain Blood in stool Rectal bleeding Distension of the abdomen Palpable mass The SimpliPro Colon test is not intended for use as a screening test or for asymptomatic patients. The SimpliPro Colon test is developed and is offered by Applied Proteomics, Inc., in its Clinical Laboratory Improvement Amendments (CLIA) certified and the College of American Pathologists (CAP) accredited laboratory in San Diego, CA. *Elevated-risk patients are defined as those who presented with the symptoms observed in the SimpliPro Colon test studies.
5 Test Attributes + Convenience = The Ideal Choice for Noninvasive Colorectal Cancer Testing Test Attributes Colorectal Cancer Advanced Adenoma 81%6 sensitivity in all stages of colorectal cancer (stages I-IV) 6 75% sensitivity in early stages of colorectal cancer (stages I-II) 6 88% sensitivity in late stages of colorectal cancer (stages III-IV) 78%6 45%6 80%6 specificity sensitivity specificity 1,6056 Patients included across multiple studies in the development of the SimpliPro Colon test.* + + = Seamless Integration Higher Compliance Early Detection through Diagnostic Colonoscopy Lower Mortality * A total of 1,605 patients were included in the development of the SimpliPro Colon test for colorectal cancer and advanced adenoma. 1,347 patients were studied for colorectal cancer only.
6 Actionable Insights Made Clear The SimpliPro Colon test results are delivered in a concise, easy-to-read report. Separate results that indicate a higher or lower risk of positive diagnosis of colorectal cancer and advanced adenoma using Applied Proteomics, Inc John Hopkins Court, Suite 150 San Diego, CA Customer Care SIMPLI ( ) Customer Care Fax LAB ( ) customercare@simpliprocolon.com Test Results Report The CAP # SimpliPro CLIA #05D Colon Test Risk Result for Patient & Practice Information Colorectal Cancer Patient Name Date of Birth (mm/dd/yyyy) Sex Medical Record/Patient Number Practice Name Ordering Physician Ordering Physician Fax The SimpliPro Colon Test Risk Result for Colorectal Cancer HIGHER A higher test result indicates a 2.8 fold increase (or a 31% probability) of a positive diagnosis of colorectal cancer, based on a clinical study of symptomatic patients referred for The SimpliPro Colon Test Risk Result for Advanced Adenoma LOWER A lower test result indicates a 1.4 fold decrease (or a 5.2% probability) of a positive diagnosis of advanced adenoma, based on a clinical study of symptomatic patients referred for Comments SimpliPro Colon Order Number Sample Collected Sample Received Sample Reported About This Test: The SimpliPro Colon test is a clinical laboratory service available only to healthcare providers for determining the risk of colorectal cancer or advanced adenoma. Results of the SimpliPro Colon test are intended to predict the likelihood of the presence of colorectal cancer or advanced adenoma, based on a study of symptomatic patients referred for diagnostic colonoscopy, and should not be used alone to determine a positive diagnosis. The test is for adjunctive use in addition to the clinical examination by a physician to aid in determining the need for a Results of the SimpliPro Colon test were validated in symptomatic patients referred for diagnostic colonoscopy and may not correlate with the percent probability determined in asymptomatic patients. Methodology: The SimpliPro Colon test uses a blood sample to test for and measure eleven proteins that have been shown in clinical studies, that when analyzed as a group, correlate with a higher or lower risk of positive diagnosis of colorectal cancer and/or advanced adenoma using The SimpliPro Colon test is performed utilizing enzymelinked immunosorbent assays (ELISA) to test for and measure the levels of the eleven proteins and utilizes a proprietary algorithm to combine the individual protein levels into a single result that is presented as a risk percentage to indicate the likelihood that patients will test positive for colorectal cancer or advanced adenoma by Based on a clinical study of symptomatic patients, the baseline risk for the presence of colorectal cancer or advanced adenoma was 10.9% and 7.4% respectively (confirmed by colonoscopy with biopsy of endoscopic lesions). Symptoms associated with the subjects in these studies included palpable mass, anemia, change in bowel habits, bleeding, weight loss, distension of the abdomen and pain. M F HIGHER A higher test result indicates a 2.8 fold increase (or a 31% probability) of a positive diagnosis of colorectal cancer, based on a clinical study of symptomatic patients referred for The SimpliPro Colon Test Risk Result for Advanced Adenoma LOWER A lower test result indicates a 1.4 fold decrease (or a 5.2% probability) of a positive diagnosis of advanced adenoma, based on a clinical study of symptomatic patients referred for Lab Director: Richard E. Safrin, MD Approval Signature Date SimpliPro Colon is a laboratory developed test developed by Applied Proteomics, Inc. (API). The performance characteristics of the test were determined by API in its San Diego, CA, clinical laboratory that is regulated by the Clinical Laboratory Improvements Amendments of 1988 (CLIA). The laboratory has been certified under the CLIA to perform high-complexity clinical testing and is also accredited by the College of American Pathologists (CAP). This test is used for clinical purposes and should not be regarded as investigational or for research. The SimpliPro Colon mark, the SimpliPro Colon logo, and the Applied Proteomics logo are trademarks of Applied Proteomics, Inc. Copyright Applied Proteomics, Inc. All rights reserved. API1-FRM-QA-0022v02
7 TM Here for You and Your Patients From Start to Finish Our Customer Care team is standing by to provide everything you need to administer the SimpliPro Colon test, coordinate shipping to our CLIA lab, and process billing and insurance claims. The SimpliPro Colon Test Process FAX Patient arrives fasted for blood work Utilizing the provided phlebotomy tools, draw the patient s blood Following the instructions for use provided, prepare the sample and package for shipping The patient s sample is analyzed via enzyme-linked immunosorbent assays (ELISA) at Applied Proteomics CLIA- certified and CAPaccredited lab Within 7-10 business days, the patient test report will be faxed to your office Billing Made Simple Applied Proteomics will Bill all private insurance and Medicare on your patients behalf Directly bill cash-paying patients Bill all applicable co-pays and deductibles Applied Proteomics, the makers of the SimpliPro Colon test, offer CarePRO, a financial assistance program that aligns with the federal poverty guidelines to assist patients who may qualify. Please contact Customer Care for more information at SIMPLI ( ).
8 The SimpliPro Colon Test Making Compliance the New Routine. The SimpliPro Colon Test Requirements Patient to fast for at least eight hours prior to blood draw. Centrifugation of sample. Samples to be shipped to our CLIA lab on dry ice. If your office does not currently have access to dry ice, please call SIMPLI ( ), and we will assist you. For more information or to learn how to order, contact: 3545 John Hopkins Court, Suite 150 San Diego, CA Customer Care SIMPLI ( ) Customer Care Fax LAB ( ) TM CAP # CLIA #05D References: 1. Gupta, Samir, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst Apr ;106(4):dju032. doi: /jnci/dju032. Epub 2014 Mar Epigenomics, Inc. Adherence to Minimally Invasive Testing (ADMIT). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) [29 June 2015]. Available from clinicaltrials.gov/ct2/show/nct (CDC) CfDCaP. Behavioral risk factor surveillance system survey data. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Levi Z, Birkenfeld S, Bilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer May 15 ;128(10): doi: /ijc SEER Cancer Center. Cancer Statistics Review , Table 6.12: Cancer of the Colon and Rectum (Invasive). html#table5sect_06_table.12.pdf. 6. Applied Proteomics, Inc. data on file. The SimpliPro Colon mark, the SimpliPro Colon logo, the CarePRO mark and the Applied Proteomics logo are trademarks of Applied Proteomics, Inc. Copyright Applied Proteomics, Inc. All rights reserved. API1-FRM-MKT-005v03
who where symptoms? colon cancer facts affected? what
who Over 130,000 new cases diagnosed each year is Greater than 50,000 deaths annually attributable to colon cancer Second leading cause of cancer death in the U.S. Equal risk in men and women Women over
More informationColonoscopy Quality Data
Colonoscopy Quality Data www.dhsgi.com Introduction Colorectal cancer is the second leading cause of cancer related deaths in the United States, in men and women combined. In 2016, there are expected to
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS What is CRC? CRC (CRC) is cancer of the large intestine (colon), the lower part of the digestive system. Rectal cancer is cancer of the last several inches of the colon. Together,
More informationScreening & Surveillance Guidelines
Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following
More informationColon Cancer Screening. A Provider Opinion Survey
Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide
More informationPATIENT BROCHURE. 441 Charmany Dr 1 Madison WI, RX Only
PATIENT BROCHURE 441 Charmany Dr 1 Madison WI, 53719 844-870- 8870 Cologuard colorectal cancer screening test is a registered trademark of Exact Sciences Corporation. Indications for Use Cologuard is intended
More informationCologuard Screening for Colorectal Cancer
Pending Policies - Medicine Cologuard Screening for Colorectal Cancer Print Number: MED208.056 Effective Date: 08-15-2016 Coverage: I.Cologuard stool DNA testing may be considered medically necessary for
More informationFECAL OCCULT BLOOD TEST
MEDICAL POLICY For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS FECAL OCCULT BLOOD TEST Policy Number: CMP - 023 Effective Date: January 1, 2018 Table
More informationRx Only. Detecting Cancer In Blood.
Epi procolon is an FDA-approved blood test for colorectal cancer screening for patients who are unwilling or unable to be screened by recommended methods. Rx Only Intended Use, Contraindications, Warnings,
More informationColon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011
Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected
More informationColorectal Cancer How to reduce your risk
Prevention Series Colorectal Cancer How to reduce your risk Let's Make Cancer History 1 888 939-3333 cancer.ca Colorectal Cancer How to reduce your risk Colorectal cancer is the third most commonly diagnosed
More informationColorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users
Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health
More informationUnfortunately you re not. So talk to your health care provider about screening today.
Unfortunately you re not. So talk to your health care provider about screening today. Fact is, Ontario has one of the highest rates of colorectal cancer in the world and thousands die from it each year.
More informationBowel cancer screening and prevention
Bowel cancer screening and prevention Cancer Incidence and Mortality Victoria 2012 Number 6000 5000 4000 3000 2000 Incidences = 29,387 Mortality = 10,780 Incidence Mortality 1000 0 Prostate Breast Bowel
More informationTransition to Fecal Immunochemical Testing (FIT)
Transition to Fecal Immunochemical Testing (FIT) Frequently Asked Questions for Primary Care Providers October 2017 Version 1.1 Overview Ontario will be transitioning from the guaiac fecal occult blood
More informationCLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING
CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace
More informationImproving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)
Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More informationColorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers
Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in
More informationCorporate Presentation. August 2016
v Corporate Presentation August 2016 Safe harbor statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
More informationColorectal Cancer Awareness: Wiping Out This Disease. Cedrek L. McFadden, MD, FACS, FASCRS
Colorectal Cancer Awareness: Wiping Out This Disease Cedrek L. McFadden, MD, FACS, FASCRS Colorectal Cancer: Statistics ~135,000 estimated new cases 2016 ~50,000 estimated deaths in 2016 (2 nd leading
More informationCorporate Presentation Fourth Quarter 2017
Corporate Presentation Fourth Quarter 2017 November 2017 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationGuidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer
Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,
More informationColorectal Cancer Screening
Tool 2.1 Cancer Screening Basic Fact Sheet Are You at High Risk? Your risk for colorectal cancer may be higher than average if: stomach You or a close relative have had colorectal polyps or colorectal
More information1101 First Colonial Road, Suite 300, Virginia Beach, VA Phone (757) Fax (757)
1101 First Colonial Road, Suite 300, Virginia Beach, VA 23454 www.vbgastro.com Phone (757) 481-4817 Fax (757) 481-7138 1150 Glen Mitchell Drive, Suite 208 Virginia Beach, VA 23456 www.vbgastro.com Phone
More informationColorectal Cancer Screening. Paul Berg MD
Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order
More informationAchieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016
Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin
More informationObjectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background
Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy
More informationMIRALAX BOWEL PREP INSTRUCTIONS
West Chester Hospital 7700 University Drive 2 nd Floor West Chester, Ohio 45069 Patient Name: MIRALAX BOWEL PREP INSTRUCTIONS Procedure Date: Arrival Time: *Please note: A colonoscopy may need to be rescheduled
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority
Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Preventive Care 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY
More informationBackground and Rationale for Gipson bill AB The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test)
Background and Rationale for Gipson bill AB 1763 The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test) The Affordable Care Act (ACA) requires all private insurers (except grandfathered
More informationColon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership
Colon Screening in 2014 Offering Patients a Choice Clark A Harrison MD The Nevada Colon Cancer Partnership Objectives 1. Understand the incidence and mortality rates for CRC in the US. 2. Understand risk
More informationQuality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care
Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:
More informationThis is the portion of the intestine which lies between the small intestine and the outlet (Anus).
THE COLON This is the portion of the intestine which lies between the small intestine and the outlet (Anus). 3 4 5 This part is responsible for formation of stool. The large intestine (colon- coloured
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed/Revised May 2018 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes
More informationCENTERS FOR DISEASE CONTROL AND PREVENTION CENTERS FOR DISEASE CONTROL AND PREVENTION. Incidence Male. Incidence Female.
A Call to Action: Prevention and Early Detection of Colorectal Cancer (CRC) 5 Key Messages Screening reduces mortality from CRC All persons aged 50 years and older should begin regular screening High-risk
More informationIEHP UM Subcommittee Approved Authorization Guidelines Colorectal Cancer Screening with Cologuard TM for Medicare Beneficiaries
for Medicare Beneficiaries Policy: Based on our review of the available evidence, the IEHP UM Subcommittee adopts the use of Cologuard TM - a multi-target stool DNA test as a colorectal cancer screening
More informationAn Updated Approach to Colon Cancer Screening and Prevention
An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention
More informationP R E S E N T S Dr. Mufa T. Ghadiali is skilled in all aspects of General Surgery. His General Surgery Services include: General Surgery Advanced Laparoscopic Surgery Surgical Oncology Gastrointestinal
More informationGI Coding Updates. Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC
GI Coding Updates Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC Copyright/Disclaimer 2014 AAPC text CPT copyright 2016 American Medical Association. All rights reserved.
More informationWellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer
Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer Healthy Habits and Cancer Screening Rev 10.20.15 Page
More informationBlue Star Sunday. Increasing Awareness About Colon Cancer. Dear Faith Community,
Blue Star Sunday Increasing Awareness About Colon Cancer Dear Faith Community, West Virginia s Cancer Coalition, Mountains of Hope, invites your faith community to participate in Colorectal Cancer Awareness
More informationColorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph:
Colorectal Cancer Screening Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL 32308 Ph: 850-297-0351 What we ll be talking about How common is colorectal cancer? What is colorectal cancer?
More informationhttps://www.uptodate.com/contents/colonoscopy-the-basics/print?source=search_result&se...
Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Colonoscopy (The Basics) Written by the doctors and editors at UpToDate What is a colonoscopy? A colonoscopy
More informationGrand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society
Grand Rounds Des Moines University May 5, 2016 Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Case Summary Mrs. J is a 56 y o w female complaining of always tired;
More informationGlobal colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University WCC, Melbourne
Global colorectal cancer screening appropriate or practical? Graeme P Young, Flinders University. 2014 WCC, Melbourne Outline WHO criteria to justify screening Appropriateness: Global variation in incidence
More informationIncreasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program
Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for
More informationHonouring the First Nations Path of Well-being
Honouring the First Nations Path of Well-being WHAT IS CANCER SCREENING? Cancer screening means taking a test that can find cancer before you have any symptoms. Finding cancer early is one of the best
More informationDiagnostics for the early detection and prevention of colorectal cancer.
Diagnostics for the early detection and prevention of colorectal cancer. Company Presentation May 2013 Safe Harbor Statement Certain statements made in this presentation contain forward-looking statements
More informationUpdate on Exact Sciences Molecular CRC Screening Test. November 16 th, 2011
Update on Exact Sciences Molecular CRC Screening Test November 16 th, 2011 0 Safe Harbor Statement Certain matters contained in this presentation, other than historical information, consist of forward-looking
More informationAnalysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,
More informationEasy Access Colonoscopy. The Oregon Clinic Gastroenterology Portland Division
Easy Access Colonoscopy The Oregon Clinic Gastroenterology Portland Division From Reynolds D, 2004. Why a colonoscopy? Colon cancer is 2 nd leading cause of death in US and is preventable ~ 56,000 deaths
More informationGet tested for. Colorectal cancer. Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside.
Get tested for Colorectal cancer Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside. 1 If you re 50 or older, you need to get tested for colorectal cancer. It s one
More informationColorectal cancer screening
26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant
More informationPhysician s Cognitive and Communication Failures Result in Cancer Treatment Delay
1 Physician s Cognitive and Communication Failures Result in Cancer Treatment Delay Abstract: The estate of a 60 year old male alleged negligence against a gastroenterologist in failing to properly evaluate
More informationQuality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Efficiency DESCRIPTION:
More informationADVISORY BULLETIN 08-IHC-04. IHC Program Member Carriers that Issue Coverage IHC Program Interested Parties
State of New Jersey DEPARTMENT OF BANKING AND INSURANCE INDIVIDUAL HEALTH COVERAGE PROGRAM PO BOX 325 TRENTON, NJ 08625-0325 JON S. CORZINE Governor TEL (609) 633-1882 FAX (609) 633-2030 STEVEN M. GOLDMAN
More informationThe most common methods currently used to investigate the colon (alone or in combination) include:
CCO No.9 Oct 2002 Before CCO decides to undertake a health technology assessment, a pre-assessment of the literature is performed. Pre-assessments are based on a limited literature search; they are not
More informationAbout Me! Fight Colorectal Cancer ABOUT COLORECTAL CANCER. Turning Catastrophic Illness into Advocacy
Fight Colorectal Cancer get behind a cure. About Me! Turning Catastrophic Illness into Advocacy Teamed up with Fight CRC in 2013 through: Call-on Congress Patient Advocate ABOUT COLORECTAL CANCER #2 cancer
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: capsule_endoscopy_wireless 5/2002 5/2016 5/2017 11/2016 Description of Procedure or Service Wireless capsule
More informationColon Investigation. Flexible Sigmoidoscopy
Colon Investigation Flexible Sigmoidoscopy What is a flexible sigmoidoscopy? Flexible sigmoidoscopy is a frequently performed test to investigate the lower part of the bowel. This is an endoscopic test
More informationGENERAL COLORECTAL CANCER INFORMATION. What is colorectal cancer?
GENERAL COLORECTAL CANCER INFORMATION What is colorectal cancer? Colorectal cancer is cancer that develops in the colon or the rectum. The colon and rectum are parts of the digestive system, which is also
More informationPolicy Specific Section: March 1, 2005 January 30, 2015
Medical Policy Fecal DNA Analysis for Colorectal Cancer Screening Type: Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: March 1, 2005
More informationEpi procolon 2.0 CE is a blood test for colorectal cancer screening.
Epi procolon 2.0 CE is a blood test for colorectal cancer screening. About Epi procolon 2.0 CE... 2 Screening Recommendations... 3 What You Should Know About Epi procolon 2.0 CE and the Septin 9 DNA Biomarker...
More informationColon, or Colorectal, Cancer Information
Colon, or Colorectal, Cancer Information Definition Colon, or colorectal, cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon). Other types of cancer can affect
More informationScreening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center
Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center Colorectal Cancer Overview Joint Guideline: American Cancer
More informationColonoscopy. patient information from your surgeon & SAGES. Colonoscopy 1
Colonoscopy patient information from your surgeon & SAGES Colonoscopy 1 Colonscopy About colonoscopy What is a colonoscopy? Colonoscopy is a procedure that enables your surgeon to examine the lining of
More informationColorectal Cancer Screening
Scan for mobile link. Colorectal Cancer Screening What is colorectal cancer screening? Screening examinations are tests performed to identify disease in individuals who lack any signs or symptoms. The
More informationCary Gastroenterology Associates Colonoscopy Consent Form
Cary Gastroenterology Associates Colonoscopy Consent Form Your physician has requested that you undergo a procedure called Colonoscopy. Colonoscopy is a procedure that enables the physician to see inside
More informationColon cancer screening : age 50 or over I'll talk to my doctor about it
Vaud Colon Cancer Screening Programme Colon cancer screening : age 50 or over I'll talk to my doctor about it Dépistage du cancer du colon Canton de Vaud Contents Help deciding and family doctor 3 Colon
More informationColorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital
Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd
More informationCorporate Presentation. First Quarter 2018
Corporate Presentation First Quarter 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
More informationAdenomatous Polyposis Syndromes (FAP/AFAP and MAP)
A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationBowel cancer Screening Programme
Bowel cancer Screening Programme 2018 What is this leaflet for? In this leaflet, you will find information about the screening programme for bowel cancer. The purpose of this leaflet is to give you information
More informationDiagnostics for the early detection and prevention of colon cancer. Leerink Swann Global Health Care Conference February 2015
Diagnostics for the early detection and prevention of colon cancer Leerink Swann Global Health Care Conference February 2015 Safe Harbor Statement Certain statements made in this news release contain forward-looking
More informationGoverning Body (Public) Meeting
ENCLOSURE: T Agenda Item: 86/13 Governing Body (Public) Meeting DATE: 25 July 2013 Title Recommended action for the Governing Body Expanding the Treatment Access Policy for Bexley That the Governing Body:
More informationCOLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST
COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST MATHEW.ESTEY@DYNALIFEDX.COM FACULTY /PRESENTER DISCLOSURE FACULTY: MATHEW ESTEY RELATIONSHIPS
More informationPATIENT DEMOGRAPHIC AND HISTORY. PATIENT INFORMATION (Please Print) Today s Date: / /
PATIENT DEMOGRAPHIC AND HISTORY PATIENT INFORMATION (Please Print) Today s Date: / / Name: Mailing Address: City/State/Zip Home phone Work Phone Cell Phone Ok to leave message: yes No Ok to leave message:
More informationAdenomatous Polyposis Syndromes (FAP/AFAP and MAP)
A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer
More informationColorectal Cancer Screening
Colorectal Cancer Screening An Integrated Care Pathway of the Collaborative Care Network Subject Matter Expert: Kevin Wolov, DO Pathway Custodian: Pat Czapp, MD First, a Friendly Reminder... This Integrated
More informationACTIVITY DISCLAIMER DISCLOSURE. Alvin B. Lin, MD, FAAFP. Audience Engagement System Step 1 Step 2 Step 3. Learning Objectives.
ACTIVITY DISCLAIMER Colorectal Cancer Alvin B. Lin, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationMKT0025 Rev Epigenomics, Inc. USA
Epi procolon and HeavyMethyl are registered trademarks of Epigenomics G, Europe, US and/or other selected countries. OC-uto is a registered trademark of Polymedco, Inc. ll other trademarks, brands, and
More informationCOLORECTAL CANCER. Colorectal Cancer (CRC) 3 rd most common cancer in U.S. 3 rd deadliest cancer in U.S. 12/4/2014
The heart and science of medicine. UVMHealth.org/CancerCenter COLORECTAL CANCER Claire Verschraegen, MD Co-Director University of Vermont Cancer Center 1 Colorectal Cancer (CRC) 3 rd most common cancer
More informationGet the facts about colon cancer. Get screened, right at home.
Get the facts about colon cancer. Of cancers that affect both men and women, colon cancer is the second leading cause of cancer-related deaths in the US. 1 Perhaps even more surprising is that it often
More informationColon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4
Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed
More informationUnderstanding COLON CANCER
Understanding What is colon cancer? Colon cancer is a disease in which cancerous cells form in the wall of the large intestine (colon) the part of your digestive system that absorbs water and turns food
More informationUpdates in Colorectal Cancer Screening & Prevention
Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University
More informationUnderstanding COLON CANCER
Understanding What is colon cancer? Colon cancer is a disease in which cancerous cells form in the wall of the large intestine (colon) the part of your digestive system that absorbs water and turns food
More informationA TEST FOR COLORECTAL CANCER THAT IS 92% SENSITIVE AND NON-INVASIVE. Stool DNA test
A TEST FOR COLORECTAL CANCER THAT IS 92% SENSITIVE AND NON-INVASIVE Stool DNA test THE NEW NON-INVASIVE SCREENING TEST FOR COLORECTAL CANCER Sensitive Clinically proven 1 Easy to use FDA approved COLOGUARD
More informationColorectal Cancer Screening
Colorectal Cancer Screening Colorectal cancer is preventable. Routine screening can reduce deaths through the early diagnosis and removal of pre-cancerous polyps. Screening saves lives, but only if people
More informationCancer Screenings and Early Diagnostics
Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6
More informationLower GI Series. National Digestive Diseases Information Clearinghouse
Lower GI Series National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is a lower gastrointestinal (GI) series? A lower GI
More informationWhat is Colorectal Cancer?
COLORECTAL CANCER (CRC) What is Colorectal Cancer? Colorectal cancer (also known as colon cancer) is cancer of the colon and/or rectum and occurs when a growth in the lining of the colon or rectum becomes
More informationUNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN
UNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN Radiology Enterprises radiologyenterprises@gmail.com www.radiologyenterprises.com STOMACH AND SMALL BOWEL STOMACH AND SMALL BOWEL Swallowed air is a
More informationThe New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society
More informationCOLONOSCOPY INSTRUCTIONS
North Shore Gastroenterology Associates, P.C. 233 East Shore Road, Suite 101 Great Neck, New York 11023 Tel: 516 487 2444 Fax: 516 487 2446 www.northshoregastro.com COLONOSCOPY INSTRUCTIONS Patient Name:
More informationJoint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.
Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,
More information